HCRx

Stamford, United States Founded: 2007 • Age: 19 yrs Acquired By KKR
Drugs for multiple therapeutic areas are manufactured through RD.

About HCRx

HCRx is a Healthcare company based in Stamford (United States) founded in 2007, and was acquired by KKR in July 2025. Drugs for multiple therapeutic areas are manufactured through RD. Its chief executive, as recorded, is Dennis Lanfear. HCRx offers products and services including Royalty Monetization and Corporate Financing. Its focus areas include Diversified Pharmaceuticals. Its legal entity is HealthCare Royalty Management, LLC.

Company details

HCRx was established in 2007 and is headquartered in Stamford, United States. Research and development efforts are directed toward the manufacturing of drugs across various therapeutic areas within the pharmaceutical sector. Operations encompass drug production processes, with a focus on healthcare applications. Services are provided to support multiple medical fields, ensuring compliance with industry standards in the U.S. market.

  • Headquarters Stamford, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website hcrx.com
  • Social LinkedIn
  • Acquired by KKR (Jul 2025)
  • Legal Name Healthcare Royalty Management, Llc
Key Metrics

Products & Services of HCRx

HCRx offers a comprehensive portfolio of products and services, including Royalty Monetization and Corporate Financing.

Royalty Monetization
Financing Service

Acquires royalties for biopharmaceutical products to provide capital.

Corporate Financing
Investment Service

Offers funding solutions for biopharmaceutical companies and products.

Investors in HCRx

HCRx has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include KKR.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Multiple sectors are invested in by this private equity firm.
1976kkr.comNew York, United States
Premium access

Investor details for HCRx

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of HCRx

19 people are tracked at HCRx (10 in leadership, 9 in team).

NameRoleGroup
Dennis Lanfear
CEOLeadership
Clarke Futch
CEOLeadership
Spencer Schneider
Chief Compliance Officer & Chief Patent CounselLeadership
Carlos Almodóvar
Chief Business OfficerLeadership
Collin Stewart
Vice PresidentLeadership
Chris White
President & CFOLeadership
Tony Rapsomanikis
Senior Managing DirectorLeadership
Andrew Logerfo
Vice PresidentLeadership
Josh House
Managing DirectorLeadership
Michele Romaniello
Senior Vice President, OperationsLeadership
Marc Kozin
Chairman, Strategy Advisory BoardTeam
Timothy Bryant
General CounselTeam
Oluwasola Ogundare
Incoming Investment Management InternTeam
Rosa Mercado
Executive AssistantTeam
Lauren Jorgensen
Executive AssistantTeam
Julie McHugh
Strategic AdvisorTeam
Tolly Flinn
Senior AssociateTeam
David B.
Advisor EU And UKTeam
Evan Bograd
Senior AssociateTeam
Premium access

Complete people profiles for HCRx

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of HCRx

2 dated milestones of HCRx across 18 years, from founding to its latest funding, stage changes and deals.

  1. Founded HCRx is founded.
  2. Exit Acquired by KKR.

Web traffic of HCRx

The website of HCRx (hcrx.com) receives about 2.8K visits a month.

  • Monthly visits
    2.8K

    ▲ 4% vs previous month

Similar websites

Websites whose visitors overlap most with HCRx. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
redhillbio.com
100%
5.7K#4,631,827View details

Top companies in Pharmaceuticals & Distribution

3 companies that operate in the same segment as HCRx (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United StatesUSD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United StatesUSD 5.33 B55,000
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Hcrx

Premium access

Complete news archive for HCRx

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about HCRx

HCRx was founded in 2007.

HCRx is headquartered in Stamford, United States. It is registered at Stamford, Connecticut, United States.

Dennis Lanfear is the CEO of HCRx, as recorded in our data.

HCRx was established in 2007 and is headquartered in Stamford, United States. Research and development efforts are directed toward the manufacturing of drugs across various therapeutic areas within the pharmaceutical sector. Operations encompass drug production processes, with a focus on healthcare applications. Services are provided to support multiple medical fields, ensuring compliance with industry standards in the U.S. market.

HCRx offers Royalty Monetization and Corporate Financing.

HCRx has 1 investor. Key investors include KKR.

HCRx operates through Healthcare Royalty Management, Llc.

Yes. HCRx was acquired by KKR in July 2025.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available